Molecular epidemiology reveals multidrug-resistant strains of Serratia marcescens in healthcare settings, highlighting infection control needs.
Purpose: Carbapenem-resistant Serratia marcescens (CRSM) poses an increasing threat in healthcare settings. This study aimed to investigate the molecular epidemiology of CRSM and the drivers of its dissemination within a hospital setting. Patients and Methods: Twelve non-duplicate clinical CRSM isolates were collected from a tertiary hospital between 2010 and 2024. Clinical data were retrospectively obtained from electronic medical records. Antimicrobial susceptibility testing was performed using the Vitek-2 system. Whole-genome sequencing (WGS) was conducted to determine resistance and virulence gene profiles, sequence types, and phylogenetic relationships. Pulsed-field gel electrophoresis and conjugation assays were performed to assess clonal relatedness and plasmid transferability. Results: CRSM infections predominantly occurred in neonates (50.0%) and adults (50.0%), with the respiratory tract as the most common infection site (66.7%). All isolates exhibited multidrug-resistant phenotypes; resistance to β-lactams ranged from 50.0% to 100.0%, while no amikacin-resistant isolates were detected. Two dominant clonal lineages were identified: ST595 (5 strains) uniformly carrying blaKPC-2 , and ST490 (6 strains, 4 of which harbored blaNDM-5 ). SNP phylogeny identified four distinct, well-supported clades, with ST595 strains showing short branch lengths indicative of clonal expansion events during the study period. The blaNDM-5 gene was successfully transferred via conjugation from four donor strains, and most transconjugants exhibited growth advantages. Core virulence genes were present in all isolates, while accessory virulence factors showed strain-specific variations. Conclusion: CRSM dissemination in this hospital is likely driven by two co-circulating high-risk clones (ST595- blaKPC-2 and ST490- blaNDM-5 ), the high horizontal transfer potential of blaNDM-5, and specific patient demographics. Despite the small sample size and single-center design, these findings provide actionable insights for infection control and antimicrobial stewardship.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: